News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
224 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (7)
2 (15)
3 (243)
4 (292)
5 (235)
6 (83)
7 (4)
8 (20)
9 (229)
10 (249)
11 (163)
12 (210)
13 (72)
14 (2)
15 (29)
16 (196)
17 (228)
18 (224)
19 (189)
20 (95)
21 (7)
22 (4)
23 (193)
24 (210)
25 (262)
26 (241)
27 (78)
28 (20)
29 (55)
30 (184)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
BioMidwest
CRISPR Research Might Lead to Cure for Duchenne Muscular Dystrophy
Researchers at the University of Missouri-Columbia, utilized CRISPR gene editing in a mouse model, to edit out the gene mutation and transplant AAV9 treated muscle into the mice.
September 18, 2019
·
3 min read
·
Mark Terry
Biotech Beach
New Test (Receptivadx) Brings Hope and New Answers for Unexplained Infertility, Failed IVF and Miscarriage
The receptivadx can have meaningful impact on women struggling with unexplained infertility by giving them an answer to their infertility. Learn more here.
September 18, 2019
·
15 min read
·
Chelsea Weidman Burke
FDA
Janssen’s Erleada Approved for New Prostate Cancer Indication
Erleada is an androgen receptor inhibitor approved for non-metastatic castration-resistant prostate cancer.
September 18, 2019
·
3 min read
·
Mark Terry
Drug Development
Alzheimer’s Disease Insight Report: Current Therapies, Drug Pipeline and Outlook
50 million people worldwide live with symptomatic Alzheimer’s, which has no cure. In honor of September 21st being World Alzheimer’s Day, we evaluated the current therapies, drugs in the pipeline and disease outlook.
September 18, 2019
·
36 min read
·
Chelsea Weidman Burke, M.S.
Business
Crescendo Biologics to collaborate with world-leading oncology groups at the University of Oxford and the University of Surrey
Crescendo Biologics Ltd announces that it has signed collaborations with world-renowned oncology research groups at the University of Oxford and the University of Surrey.
September 18, 2019
·
5 min read
Pharm Country
Oncoceutics Commemorates National Childhood Cancer Awareness Month
Oncoceutics, a clinical-stage drug discovery and development company, commemorates National Childhood Cancer Awareness Month this September and reiterates its support for children and all those affected by childhood cancer.
September 18, 2019
·
2 min read
Bio NC
Rho Named to Best Places to Work List by Triangle Business Journal for the Eighth Time
Rho announced that the Triangle Business Journal has named the company a winner of the Best Places to Work award in the Triangle.
September 18, 2019
·
1 min read
Deals
AML biotech Race Oncology (RAC) strengthens board with prominent biotech investor Dr Daniel Tillet
Race Oncology Limited is pleased to announce that prominent biotechnology investor and substantial Race shareholder, Dr Daniel Tillett, has joined the Board of Directors of Race Oncology Ltd.
September 18, 2019
·
2 min read
Deals
CMR Surgical raises £195 million ($240 million) in Series C financing
CMR Surgical Limited announces that it has raised £195 million ($240 million) to fully fund the global commercialisation of the business.
September 18, 2019
·
5 min read
Vygon launches Surfcath, a novel catheter for smoother administration of surfactant in premature babies with Respiratory Distress Syndrome
Surfcath eliminates need for Magill forceps during Less Invasive Surfactant Administration (LISA) method in preterm babies
September 18, 2019
·
3 min read
1 of 23
Next